© 2022 MJH Life Sciences and Oncology Nursing News. All rights reserved.
© 2022 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
April 21, 2017
Adverse Events Report
The adverse events report featuring FDA labeling changes for bendamustine hydrochloride, nilotinib, dinutuximab.
April 20, 2017
The ever-growing number of cancer survivors means that practitioners across the healthcare spectrum need to step up to an active and dynamic role in their care.
April 19, 2017
The voice of the patient during clinical trials must be captured, to fully record the impact of treatment toxicity and symptoms.
Clinical Trials in Progress
An ongoing trial is evaluating the addition of PARP inhibitor velaparib to a chemotherapy combination, for patients with HER2-negative, germline BRCA-associated metastatic or locally advanced breast cancer.
April 17, 2017
Nurses may think that if they are careful, their routine drug administration activities will not result in hazardous drug leaking and exposure, but even small leaks are problematic.
April 14, 2017
Patients with cancer know all too well the worry that accompanies waiting for test results. What can healthcare providers do to help?
April 13, 2017
Language barriers can mean patients put off preventive screenings, and even treatment, for fear of being misunderstood by their healthcare providers.
April 12, 2017
Fast Facts for the Frontline
Many anticancer therapies increase the risk of oral mucositis, leading to dose reduction or treatment delays. There are interventions that can help, and more are under study.
April 10, 2017
From the Chairman